Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-063729
Filing Date
2015-11-09
Accepted
2015-11-09 16:05:45
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v423200_10q.htm 10-Q 243491
2 EXHIBIT 31.1 v423200_ex31-1.htm EX-31.1 7626
3 EXHIBIT 31.2 v423200_ex31-2.htm EX-31.2 7875
4 EXHIBIT 32.1 v423200_ex32-1.htm EX-32.1 3674
5 EXHIBIT 32.2 v423200_ex32-2.htm EX-32.2 3643
  Complete submission text file 0001144204-15-063729.txt   3040205

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT asmb-20150930.xml EX-101.INS 567740
7 XBRL TAXONOMY EXTENSION SCHEMA asmb-20150930.xsd EX-101.SCH 38858
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asmb-20150930_cal.xml EX-101.CAL 37287
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asmb-20150930_def.xml EX-101.DEF 231174
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20150930_lab.xml EX-101.LAB 290473
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20150930_pre.xml EX-101.PRE 262361
Mailing Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013
Business Address 99 HUDSON STREET 5TH FLOOR NEW YORK NY 10013 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 151215601
SIC: 2834 Pharmaceutical Preparations